Biologics and Personalized Medicine in Severe Asthma: One Step at a Time

被引：0
作者：
Beasley, Richard [1 ,2 ]
Hatter, Lee [1 ]
机构：
[1] Med Res Inst New Zealand, Wellington, New Zealand
[2] Med Res Inst New Zealand, Private Bag 7902, Wellington 6242, New Zealand
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2023年 / 11卷 / 06期
关键词：
D O I：
10.1016/j.jaip.2023.04.022
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1771 / 1772
页数：2
相关论文
共 11 条
  • [1] The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review
    Beasley, Richard
    Bruce, Pepa
    Houghton, Claire
    Hatter, Lee
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 11 (03) : 762 - +
  • [2] Inhaled Corticosteroid Therapy in Adult Asthma Time for a New Therapeutic Dose Terminology
    Beasley, Richard
    Harper, James
    Bird, Grace
    Maijers, Ingrid
    Weatherall, Mark
    Pavord, Ian D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (12) : 1471 - 1477
  • [3] Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
    Bel, Elisabeth H.
    Wenzel, Sally E.
    Thompson, Philip J.
    Prazma, Charlene M.
    Keene, Oliver N.
    Yancey, Steven W.
    Ortega, Hector G.
    Pavord, Ian D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13) : 1189 - 1197
  • [4] Assessment of Real-World Escalation to Biologics in US Patients With Asthma
    Bender, Bruce
    Oppenheimer, John
    George, Maureen
    Brown, Randall
    Patel, Ayush
    Hill, Tanisha
    Boe, Amanda
    Herrera, Ernesto Mayen
    Dotiwala, Zenobia
    Casciano, Julian
    Bernstein, Jonathan A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (11) : 2941 - 2948
  • [5] Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities
    Casale, Thomas
    Molfino, Nestor A.
    Silver, Jared
    Bogart, Michael
    Packnett, Elizabeth
    McMorrow, Donna
    Wu, Joanne
    Hahn, Beth
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (03) : 354 - +
  • [6] Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials
    Chen, Wenjia
    Reddel, Helen K.
    FitzGerald, J. Mark
    Beasley, Richard
    Janson, Christer
    Sadatsafavi, Mohsen
    [J]. RESPIRATORY RESEARCH, 2023, 24 (01)
  • [7] Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial (vol 9 pg 260, 2021)
    Harrison, Tim W.
    Chanez, Pascal
    Menzella, Francesco
    Canonica, Giorgio Walter
    Louis, Renaud
    Cosio, Borja G.
    Lugogo, Njira L.
    Mohan, Arjun
    Burden, Annie
    McDermott, Lawrence
    Garcia Gil, Esther
    Zangrilli, James G.
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (03) : E29 - E29
  • [8] Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma
    Holgate, ST
    Chuchalin, AG
    Hébert, J
    Lötvall, J
    Persson, GB
    Chung, KF
    Bousquet, J
    Kerstjens, HA
    Fox, H
    Thirlwell, J
    Della Cioppa, G
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (04) : 632 - 638
  • [9] Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
    Louis, Renaud
    Harrison, Tim W.
    Chanez, Pascal
    Menzella, Francesco
    Philteos, George
    Cosio, Borja G.
    Lugogo, Njira L.
    de Luiz, Gustavo
    Burden, Annie
    Adlington, Timothy
    Keeling, Nanna
    Kwiatek, Justin
    Gil, Esther Garcia
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (06) : 1759 - +
  • [10] Biologic use and outcomes among adults with severe asthma treated by US subspecialists
    Panettieri, Reynold A., Jr.
    Ledford, Dennis K.
    Chipps, Bradley E.
    Soong, Weily
    Lugogo, Njira
    Carr, Warner
    Mohan, Arjun
    Carstens, Donna
    Genofre, Eduardo
    Trudo, Frank
    Ambrose, Christopher S.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 (04) : 467 - +
12